CGEM

Cullinan Therapeutics, Inc.

CIK 0001789972 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)

$21.68

↑ 0.30 (1.40%)

as of Aug 21, 2026

End-of-day close, not real-time intraday

Live price (Google Finance) ↗

Overall read: NeutralOverall score · based on 4/4 lenses

FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals

Key stats

Market Cap

$1.33B

P/E Ratio

-6.51

EPS

Not covered

Dividend Yield

Not covered

52W Position

95%

Beta

1.33

Valuation multiples

Fwd P/E

6.74

PEG

Not covered

P/B

4.14

P/S

Not covered

EV/Revenue

Not covered

ROE

-63.6%

Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 95%

$5.68$22.54

Latest Financials

2025-12-31 FY

Revenue

–

Net Income

-$219.88M

Total Assets

$448.37M

Free Cash Flow

-$175.80M

CGEM

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news

CGEM

Key stats

Valuation multiples

Price · 1Y

Latest Financials

Recent news